Latest Breaking News On - Mindbio therapeutics corp - Page 4 : comparemela.com

MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing

MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing .

British columbiaJustin hankaMindbio justin hankaFood drug administrationNeither the canadian securities exchangeCanadian securities exchangeCompany or mindbioRegulation service providerNews networkMindbio therapeutics corpMindbio therapeuticsMajor depressiveMajor depressive disorderMontgomery asberg depression rating scaleDrug administrationExecutive officer

MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing (MB22001) Clinical Trial in Depressed Patients

MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing (MB22001) Clinical Trial in Depressed Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaJustin hankaMindbio justin hankaMindbio therapeutics corpRegulation service providerFood drug administrationCanadian securities exchangeCompany or mindbioNeither the canadian securities exchangeMindbio therapeuticsMajor depressiveMajor depressive disorderMontgomery asberg depression rating scaleDrug administrationExecutive officerChief executive

MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing Clinical Trial in Depressed Patients

MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing Clinical Trial in Depressed Patients
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

British columbiaMindbio justin hankaStefan klotterJustin hankaRegulation service providerMindbio therapeutics corpCompany or mindbioFood drug administrationCanadian securities exchangeNeither the canadian securities exchangeMindbio therapeuticsMajor depressiveMajor depressive disorderMontgomery asberg depression rating scaleDrug administrationExecutive officer

MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing (MB22001) Clinical Trial

VANCOUVER, BC / ACCESSWIRE / January 30, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), announces it is nearing the completion of its Phase 2a clinical trial using MB22001 in patients with Major Depressive Disorder.MindBio is pleased to report that dosi.

British columbiaJustin hankaMindbio justin hankaFood drug administrationCompany or mindbioMindbio therapeutics corpCanadian securities exchangeRegulation service providerNeither the canadian securities exchangeMindbio therapeuticsMajor depressiveMajor depressive disorderMontgomery asberg depression rating scaleDrug administrationExecutive officerChief executive

MindBio Therapeutics Team Members Honoured with Industry Leading Awards

MindBio Therapeutics Team Members Honoured with Industry Leading Awards
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaJustin hankaSuresh muthukumaraswamyCanadian securities exchangeNeither the canadian securities exchangeMindbio therapeutics corpCompany or mindbioRegulation service providerMindbio therapeuticsChief executive officerChief executiveLysergic acid diethylamideMajor depressive disorderNote concerning forward looking statements